|
MID1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.028120E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.084680E-03 |
| Normal-vs-Stage2 |
3.356600E-01 |
| Normal-vs-Stage3 |
1.887200E-01 |
| Normal-vs-Stage4 |
8.998000E-01 |
| Stage1-vs-Stage2 |
2.808200E-01 |
| Stage1-vs-Stage3 |
1.476620E-01 |
| Stage1-vs-Stage4 |
3.396100E-03 |
| Stage2-vs-Stage3 |
9.921800E-01 |
| Stage2-vs-Stage4 |
3.934600E-01 |
| Stage3-vs-Stage4 |
2.536200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.546300E-02 |
| Normal-vs-AfricanAmerican |
2.880300E-02 |
| Normal-vs-Asian |
6.107000E-01 |
| Caucasian-vs-AfricanAmerican |
1.196200E-01 |
| Caucasian-vs-Asian |
8.664200E-01 |
| AfricanAmerican-vs-Asian |
5.031400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.878400E-02 |
| Normal-vs-Female |
7.875300E-03 |
| Male-vs-Female |
3.595200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.379800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.558100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.919500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.635200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.506200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.447200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.209600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.311000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.730030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.335600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.848300E-02 |
| Normal-vs-Grade 2 |
1.544920E-03 |
| Normal-vs-Grade 3 |
1.555240E-01 |
| Normal-vs-Grade 4 |
7.721000E-01 |
| Grade 1-vs-Grade 2 |
4.106200E-01 |
| Grade 1-vs-Grade 3 |
1.745420E-01 |
| Grade 1-vs-Grade 4 |
4.420000E-02 |
| Grade 2-vs-Grade 3 |
3.248100E-02 |
| Grade 2-vs-Grade 4 |
1.950370E-02 |
| Grade 3-vs-Grade 4 |
3.967000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.002800E-03 |
| Normal-vs-ccB subtype |
4.604200E-02 |
| ccA subtype-vs-ccB subtype |
8.511000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.365500E-02 |
| Normal-vs-N1 |
4.321800E-01 |
| N0-vs-N1 |
6.349000E-01 |
|
|
